[
  {
    "ts": null,
    "headline": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
    "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
    "url": "https://finnhub.io/api/news?id=302fffc394e1d75dcc2acefe27c16e7eb19bb87eb9c471cadc7b89553b9e2394",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760726478,
      "headline": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
      "id": 137130686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
      "url": "https://finnhub.io/api/news?id=302fffc394e1d75dcc2acefe27c16e7eb19bb87eb9c471cadc7b89553b9e2394"
    }
  },
  {
    "ts": null,
    "headline": "What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation",
    "summary": "Thermo Fisher Scientific recently announced a collaboration with OpenAI to integrate advanced artificial intelligence into its Accelerator Drug Development solution, aiming to enhance the speed and success rate of drug development for its customers. This partnership highlights the growing role of AI in accelerating clinical trials and streamlining therapeutic discovery, positioning Thermo Fisher Scientific at the forefront of digital transformation in the life sciences industry. We'll...",
    "url": "https://finnhub.io/api/news?id=9d31076bf3b7d511b19a56aca3e3d06d2577fd2ffe409b6cdc7f83a53c19bd34",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760714262,
      "headline": "What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation",
      "id": 137127565,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific recently announced a collaboration with OpenAI to integrate advanced artificial intelligence into its Accelerator Drug Development solution, aiming to enhance the speed and success rate of drug development for its customers. This partnership highlights the growing role of AI in accelerating clinical trials and streamlining therapeutic discovery, positioning Thermo Fisher Scientific at the forefront of digital transformation in the life sciences industry. We'll...",
      "url": "https://finnhub.io/api/news?id=9d31076bf3b7d511b19a56aca3e3d06d2577fd2ffe409b6cdc7f83a53c19bd34"
    }
  },
  {
    "ts": null,
    "headline": "Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics",
    "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
    "url": "https://finnhub.io/api/news?id=5c6f18f7e4685621c06332e605c0dadfd9c5bd1673b63298e7ac40731ee2c66a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760706903,
      "headline": "Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics",
      "id": 137125782,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
      "url": "https://finnhub.io/api/news?id=5c6f18f7e4685621c06332e605c0dadfd9c5bd1673b63298e7ac40731ee2c66a"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
    "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
    "url": "https://finnhub.io/api/news?id=0df0f03705a7af5982f3c39144f0d3a9b9e0c43beb285e3bd7a7385752ebf734",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760706540,
      "headline": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
      "id": 137125783,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
      "url": "https://finnhub.io/api/news?id=0df0f03705a7af5982f3c39144f0d3a9b9e0c43beb285e3bd7a7385752ebf734"
    }
  }
]